Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Associations of insomnia on pregnancy and perinatal outcomes: Findings from Mendelian randomization and conventional observational studies in up to 356,069 women

Qian Yang, M. Carolina Borges, View ORCID ProfileEleanor Sanderson, Maria C. Magnus, Fanny Kilpi, Paul J. Collings, View ORCID ProfileAna Luiza Soares, Jane West, Per Magnus, John Wright, Siri E. Håberg, Kate Tilling, Deborah A. Lawlor
doi: https://doi.org/10.1101/2021.10.07.21264689
Qian Yang
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: qian.yang@bristol.ac.uk
M. Carolina Borges
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor Sanderson
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eleanor Sanderson
Maria C. Magnus
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
3Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanny Kilpi
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J. Collings
4Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Luiza Soares
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana Luiza Soares
Jane West
4Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Magnus
3Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Wright
4Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siri E. Håberg
3Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Tilling
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
5National Institute for Health Research Bristol Biomedical Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah A. Lawlor
1MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK
2Population Health Sciences, Bristol Medical School, University of Bristol, UK
5National Institute for Health Research Bristol Biomedical Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Insomnia is common and associated with adverse pregnancy and perinatal outcomes in observational studies. Our aim was to test whether insomnia causes stillbirth, miscarriage, gestational diabetes, hypertensive disorders of pregnancy, perinatal depression, preterm birth, or low/high offspring birthweight (LBW/HBW).

Methods and Findings We used two-sample Mendelian randomization (MR) with 81 single nucleotide polymorphisms instrumenting for a lifelong predisposition to insomnia. We used data (N=356,069) from the UK Biobank, FinnGen, and three European birth cohorts (Avon Longitudinal Study of Parents and Children (ALSPAC), Born in Bradford, and Norwegian Mother, Father and Child Cohort Study). Main MR analyses used inverse variance weighting (IVW), with weighted median and MR-Egger as sensitivity analyses. We compared MR estimates with multivariable regression of insomnia in pregnancy on outcomes in ALSPAC (N=11,745). IVW showed evidence of an effect of genetic susceptibility to insomnia on miscarriage (odds ratio (OR): 1.60, 95% confidence interval (CI): 1.18, 2.17), perinatal depression (OR 3.56, 95% CI: 1.49, 8.54) and LBW (OR 3.17, 95% CI: 1.69, 5.96). For other outcomes IVW indicated potentially clinically important adverse effects of insomnia (OR range 1.20 to 2.43), but CIs were wide and included the null. Weighted median and MR Egger results were directionally consistent, except for MR-Egger for gestational diabetes, perinatal depression, and preterm birth. Multivariable regression showed associations of insomnia at 18 weeks of gestation with miscarriage (OR 1.30, 95% CI: 1.12, 1.51), stillbirth (OR 2.10, 95% CI: 1.20, 3.69), and perinatal depression (OR 2.96, 95% CI: 2.42, 3.63), but not with LBW (OR 0.92, 95% CI: 0.69, 1.24). Key limitations are potential horizontal pleiotropy and low statistical power in MR, and residual confounding in multivariable regression.

Conclusions There is evidence of causal effects of insomnia on miscarriage, perinatal depression, and LBW. We highlight the need for larger studies with genomic data and pregnancy outcomes.

Why was this study done?

  • Insomnia in pregnancy was associated with higher risks of adverse pregnancy and perinatal outcomes in observational studies.

  • It is currently no clear whether insomnia causes adverse pregnancy and perinatal outcomes or whether the unfavourable associations are explained by confounding.

  • No Mendelian randomization has been conducted to explore the association of insomnia with adverse pregnancy and perinatal outcomes.

What did the researchers do and find?

  • We used data on up to 356,069 women from UK Biobank, FinnGen and three birth cohorts, and assessed whether genetic susceptibility to insomnia was associated with stillbirth, miscarriage, gestational diabetes, hypertensive disorders of pregnancy, perinatal depression, preterm birth, low offspring birthweight, and high offspring birthweight in two-sample Mendelian randomization.

  • To triangulate with our Mendelian randomization estimates, we conducted multivariable regression in 11,745 women from the Avon Longitudinal Study of Parents and Children, where insomnia was measured in pregnancy.

  • We found consistent evidence from Mendelian randomization and multivariable regression that insomnia was associated with higher risks miscarriage and perinatal depression, and Mendelian randomization also suggested an unfavourable effect on low offspring birthweight.

What do these findings mean?

  • Interventions to improve healthy sleep in women of reproductive age might be beneficial to a healthy pregnancy.

Competing Interest Statement

KT has acted as a consultant for CHDI Foundation. DAL has received support from Medtronic LTD and Roche Diagnostics for biomarker research that is not related to the study presented in this paper. The other authors report no conflicts.

Funding Statement

This work was supported by the University of Bristol and UK Medical Research Council (MM_UU_00011/1, MM_UU_00011/3 and MM_UU_00011/6), the US National Institute for Health (R01 DK10324), the European Research Council via Advanced Grant 669545, the British Heart Foundation (AA/18/7/34219 and CS/16/4/32482) and the National Institute of Health Research Bristol Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. Q.Y. is funded by a China Scholarship Council PhD Scholarship (CSC201808060273). M.C.B. was funded by a UK Medical Research Council Skills Development Fellowship (MR/P014054/1) and a University of Bristol Vice Chancellor Fellowship during her contribution to this research. M.C.M. has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement No 947684). M.C.M and S.E.H are partly funded by the Research Council of Norway through its Centres of Excellence funding scheme (project No 262700). P.J.C. is funded by a British Heart Foundation Immediate Postdoctoral Basic Science Research Fellowship (FS/17/37/32937). D.A.L. is a British Heart Foundation Chair (CH/F/20/90003) and a National Institute of Health Research Senior Investigator (NF-0616-10102). The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and D.A.L will serve as guarantor for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf); This research was specifically funded by Wellcome Trust (WT088806), and child's GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. BiB receives core funding from the Wellcome Trust (WT101597MA), a joint grant from the UK Medical and Economic and Social Science Research Councils (MR/N024397/1), British Heart Foundation (CS/16/4/32482), and the National Institute of Health Research under its Applied Research Collaboration for Yorkshire and Humber and Clinical Research Network research delivery support. Further support for genome-wide and multiple 'omics measurements in BiB is from the UK Medical Research Council (G0600705), National Institute of Health Research (NF-SI-0611-10196), US National Institute of Health (R01DK10324), and the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no 669545. The funders had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication. The views expressed in this paper are those of the authors and not necessarily those of any funder.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for UKB was obtained from the North West Multi-centre Research Ethics Committee, and our study was performed under UKB application number 23938. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Consent for biological samples has been collected in accordance with the Human Tissue Act (2004). Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendation of the ALSPAC Ethics and Law Committee at the time. Ethical approval for BiB was obtained from the Bradford Research Ethics Committee. The establishment of MoBa and initial data collection was based on a license from the Norwegian Data Protection Agency and approval from The Regional Committees for Medical and Health Research Ethics. The MoBa cohort is now based on regulations related to the Norwegian Health Registry Act. The current study was approved by The Regional Committees for Medical and Health Research Ethics. The Coordinating Ethics Committee of the Helsinki and Uusimaa Hospital District has approved the FinnGen consortium (Nr HUS/990/2017), and this study only used its summary level data.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We used both individual participant cohort data and publicly available summary statistics. We present summary statistics that we generated from those individual participant cohort data in S4 & 5 Tables. Full information on how to access UKB data can be found at its website (https://www.ukbiobank.ac.uk/researchers/). All ALSPAC data are available to scientists on request to the ALSPAC Executive via this website (http://www.bristol.ac.uk/alspac/researchers/), which also provides full details and distributions of the ALSPAC study variables. Similarly, data from BiB are available on request to the BiB Executive (https://borninbradford.nhs.uk/research/how-to-access-data/). Data from MoBa are available from the Norwegian Institute of Public Health after application to the MoBa Scientific Management Group (see its website https://www.fhi.no/en/op/data-access-from-health-registries-health-studies-and-biobanks/data-access/applying-for-access-to-data/ for details). Summary statistics from FinnGen are publicly available on its website (https://finngen.gitbook.io/documentation/data-download).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted October 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Associations of insomnia on pregnancy and perinatal outcomes: Findings from Mendelian randomization and conventional observational studies in up to 356,069 women
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Associations of insomnia on pregnancy and perinatal outcomes: Findings from Mendelian randomization and conventional observational studies in up to 356,069 women
Qian Yang, M. Carolina Borges, Eleanor Sanderson, Maria C. Magnus, Fanny Kilpi, Paul J. Collings, Ana Luiza Soares, Jane West, Per Magnus, John Wright, Siri E. Håberg, Kate Tilling, Deborah A. Lawlor
medRxiv 2021.10.07.21264689; doi: https://doi.org/10.1101/2021.10.07.21264689
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Associations of insomnia on pregnancy and perinatal outcomes: Findings from Mendelian randomization and conventional observational studies in up to 356,069 women
Qian Yang, M. Carolina Borges, Eleanor Sanderson, Maria C. Magnus, Fanny Kilpi, Paul J. Collings, Ana Luiza Soares, Jane West, Per Magnus, John Wright, Siri E. Håberg, Kate Tilling, Deborah A. Lawlor
medRxiv 2021.10.07.21264689; doi: https://doi.org/10.1101/2021.10.07.21264689

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (141)
  • Cardiovascular Medicine (1955)
  • Dentistry and Oral Medicine (253)
  • Dermatology (186)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11118)
  • Forensic Medicine (8)
  • Gastroenterology (629)
  • Genetic and Genomic Medicine (3192)
  • Geriatric Medicine (309)
  • Health Economics (565)
  • Health Informatics (2048)
  • Health Policy (864)
  • Health Systems and Quality Improvement (788)
  • Hematology (310)
  • HIV/AIDS (684)
  • Infectious Diseases (except HIV/AIDS) (12738)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (318)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2999)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1560)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2795)
  • Public and Global Health (5609)
  • Radiology and Imaging (1100)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (764)
  • Rheumatology (340)
  • Sexual and Reproductive Health (314)
  • Sports Medicine (289)
  • Surgery (347)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)